CEP15
gene geneOn this page
Also known as HT021
Summary
CEP15 (centrosomal protein 15, HGNC:25024) is a protein-coding gene on chromosome 3p14.2, encoding Centrosomal protein 15 (Q9HBI5). May play a role in ciliary assembly.
Predicted to be located in cilium.
Source: NCBI Gene 57415 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 7 total
- MANE Select transcript:
NM_001291941
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:25024 |
| Approved symbol | CEP15 |
| Name | centrosomal protein 15 |
| Location | 3p14.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | HT021 |
| Ensembl gene | ENSG00000114405 |
| Ensembl biotype | protein_coding |
| Entrez | 57415 |
Gene structure
Transcript identifiers
Ensembl transcripts: 8 — 6 protein_coding, 1 protein_coding_CDS_not_defined, 1 retained_intron
ENST00000232519, ENST00000462069, ENST00000465142, ENST00000486169, ENST00000491323, ENST00000494481, ENST00000542214, ENST00000960035
RefSeq mRNA: 4 — MANE Select: NM_001291941
NM_001291941, NM_001291942, NM_001291943, NM_020685
CCDS: CCDS2896
Canonical transcript exons
ENST00000462069 — 6 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000773526 | 62331325 | 62331399 |
| ENSE00001362263 | 62319721 | 62319832 |
| ENSE00001865441 | 62319022 | 62319055 |
| ENSE00001881480 | 62333255 | 62336213 |
| ENSE00003487810 | 62321930 | 62322053 |
| ENSE00003567974 | 62320460 | 62320524 |
Expression profiles
Bgee: expression breadth ubiquitous, 272 present calls, max score 97.98.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 13.6319 / max 158.0113, expressed in 1506 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 37110 | 12.3081 | 1493 |
| 37111 | 0.8407 | 345 |
| 37112 | 0.4830 | 218 |
Top tissues by expression
286 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| pons | UBERON:0000988 | 97.98 | gold quality |
| cortical plate | UBERON:0005343 | 97.98 | gold quality |
| endothelial cell | CL:0000115 | 97.87 | gold quality |
| ganglionic eminence | UBERON:0004023 | 97.50 | gold quality |
| middle temporal gyrus | UBERON:0002771 | 97.00 | gold quality |
| lateral nuclear group of thalamus | UBERON:0002736 | 96.58 | gold quality |
| orbitofrontal cortex | UBERON:0004167 | 95.97 | gold quality |
| superior vestibular nucleus | UBERON:0007227 | 95.95 | gold quality |
| substantia nigra pars compacta | UBERON:0001965 | 95.78 | gold quality |
| Brodmann (1909) area 23 | UBERON:0013554 | 95.46 | gold quality |
| amygdala | UBERON:0001876 | 95.42 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 95.36 | gold quality |
| prefrontal cortex | UBERON:0000451 | 95.35 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 95.32 | gold quality |
| cingulate cortex | UBERON:0003027 | 95.29 | gold quality |
| dorsal root ganglion | UBERON:0000044 | 95.22 | gold quality |
| temporal lobe | UBERON:0001871 | 95.16 | gold quality |
| islet of Langerhans | UBERON:0000006 | 95.12 | gold quality |
| neocortex | UBERON:0001950 | 95.04 | gold quality |
| frontal cortex | UBERON:0001870 | 95.03 | gold quality |
| parietal lobe | UBERON:0001872 | 95.02 | gold quality |
| postcentral gyrus | UBERON:0002581 | 94.96 | gold quality |
| cerebral cortex | UBERON:0000956 | 94.89 | gold quality |
| substantia nigra pars reticulata | UBERON:0001966 | 94.89 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 94.87 | gold quality |
| entorhinal cortex | UBERON:0002728 | 94.80 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 94.53 | gold quality |
| right frontal lobe | UBERON:0002810 | 94.52 | gold quality |
| sperm | CL:0000019 | 94.46 | gold quality |
| nucleus accumbens | UBERON:0001882 | 94.35 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 2.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-CURD-114 | yes | 12.42 |
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
112 targeting CEP15, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-30A-5P | 100.00 | 76.31 | 3233 |
| HSA-MIR-30B-5P | 100.00 | 76.29 | 3248 |
| HSA-MIR-30C-5P | 100.00 | 76.29 | 3248 |
| HSA-MIR-30D-5P | 100.00 | 76.32 | 3233 |
| HSA-MIR-30E-5P | 100.00 | 76.32 | 3242 |
| HSA-MIR-190A-3P | 100.00 | 80.35 | 5520 |
| HSA-MIR-371B-5P | 99.99 | 75.34 | 4759 |
| HSA-MIR-4531 | 99.99 | 69.70 | 3181 |
| HSA-MIR-513B-5P | 99.99 | 69.96 | 2150 |
| HSA-MIR-548P | 99.98 | 72.25 | 3784 |
| HSA-MIR-373-5P | 99.98 | 75.36 | 4753 |
| HSA-MIR-616-5P | 99.98 | 75.58 | 4775 |
| HSA-MIR-4775 | 99.98 | 75.00 | 6394 |
| HSA-MIR-12136 | 99.98 | 72.81 | 5713 |
| HSA-MIR-3148 | 99.97 | 75.06 | 6478 |
| HSA-MIR-3688-3P | 99.97 | 72.02 | 2834 |
| HSA-MIR-570-3P | 99.96 | 72.41 | 4910 |
| HSA-MIR-3605-5P | 99.96 | 67.12 | 932 |
| HSA-MIR-1468-3P | 99.96 | 72.74 | 3797 |
| HSA-MIR-548AA | 99.96 | 70.64 | 3753 |
| HSA-MIR-548AP-3P | 99.96 | 70.64 | 3753 |
| HSA-MIR-548T-3P | 99.96 | 70.64 | 3753 |
| HSA-MIR-548AJ-3P | 99.96 | 73.38 | 5345 |
| HSA-MIR-548X-3P | 99.96 | 73.38 | 5345 |
| HSA-MIR-302E | 99.96 | 70.74 | 2669 |
| HSA-MIR-141-3P | 99.94 | 72.79 | 2421 |
| HSA-MIR-200A-3P | 99.94 | 72.68 | 2420 |
| HSA-MIR-548J-3P | 99.94 | 72.61 | 4881 |
| HSA-MIR-4525 | 99.94 | 64.38 | 675 |
| HSA-MIR-5010-5P | 99.94 | 64.11 | 705 |
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | CEP15 | ENSDARG00000086324 |
| mus_musculus | Cep15 | ENSMUSG00000033111 |
| rattus_norvegicus | Cep15 | ENSRNOG00000039871 |
Protein
Protein identifiers
Centrosomal protein 15 — Q9HBI5 (reviewed: Q9HBI5)
Alternative names: Centrosomal protein 15 kDa
All UniProt accessions (2): Q9HBI5, C9JY17
UniProt curated annotations — full annotation on UniProt →
Function. May play a role in ciliary assembly.
Subcellular location. Cell projection. Cilium.
RefSeq proteins (4): NP_001278870, NP_001278871, NP_001278872, NP_065736 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR028006 | CEP15-like | Family |
Pfam: PF15134
UniProt features (1 total): chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9HBI5-F1 | 86.33 | 0.63 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 135 (showing top):
GSE45365_CD8A_DC_VS_CD11B_DC_IFNAR_KO_UP, GSE37336_LY6C_POS_VS_NEG_NAIVE_CD4_TCELL_UP, GSE18804_BRAIN_VS_COLON_TUMORAL_MACROPHAGE_UP, GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN, RODWELL_AGING_KIDNEY_NO_BLOOD_DN, WEI_MYCN_TARGETS_WITH_E_BOX, MODULE_205, RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP, GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN, RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN, HP1SITEFACTOR_Q6, OCT1_06, LIAO_METASTASIS, GARCIA_TARGETS_OF_FLI1_AND_DAX1_DN, CREB_Q2_01
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (2): cilium (GO:0005929), cell projection (GO:0042995)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| intraciliary transport particle | 1 |
| membrane-bounded organelle | 1 |
| plasma membrane bounded cell projection | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
450 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| CEP15 | J3KS56 | J3KS56 | 589 |
| CEP15 | CEP89 | Q96ST8 | 577 |
| CEP15 | CCDC77 | Q9BR77 | 559 |
| CEP15 | CCDC150 | Q8NCX0 | 559 |
| CEP15 | RIBC2 | Q9H4K1 | 528 |
| CEP15 | C9orf40 | Q8IXQ3 | 506 |
| CEP15 | OTULINL | Q9NUU6 | 460 |
| CEP15 | ZNF367 | Q7RTV3 | 455 |
| CEP15 | SATL1 | Q86VE3 | 449 |
| CEP15 | DONSON | Q9NYP3 | 447 |
| CEP15 | GOLGA8H | P0CJ92 | 447 |
| CEP15 | TTC1 | Q99614 | 433 |
| CEP15 | MGME1 | Q9BQP7 | 425 |
| CEP15 | MRPL50 | Q8N5N7 | 402 |
| CEP15 | OR13A1 | Q8NGR1 | 393 |
IntAct
9 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| CEP15 | SERPINA12 | psi-mi:“MI:0915”(physical association) | 0.400 |
| MAPT | SHTN1 | psi-mi:“MI:0914”(association) | 0.350 |
| CEP15 | POTEF | psi-mi:“MI:0914”(association) | 0.350 |
| CEP89 | CCDC66 | psi-mi:“MI:2364”(proximity) | 0.270 |
| CEP15 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (10): C3orf14 (Proximity Label-MS), C3orf14 (Affinity Capture-RNA), SERPINA12 (Affinity Capture-MS), YES1 (Affinity Capture-MS), NCS1 (Affinity Capture-MS), SMPDL3B (Affinity Capture-MS), CEP89 (Affinity Capture-MS), POTEF (Affinity Capture-MS), DDX3Y (Affinity Capture-MS), C3orf14 (Proximity Label-MS)
ESM2 similar proteins: A3KQI3, A4GCK2, A4GZV0, A4WBQ9, A7MEF1, A7SGF0, B2VJD3, D4GGV4, D4HVG6, O17213, O32124, O84672, O85806, P13313, P24445, P37588, P69266, P69267, Q01048, Q08545, Q18446, Q39236, Q4R8E8, Q4S3C1, Q4V8P4, Q4V8S9, Q5RK03, Q67173, Q6FJ19, Q6XTK1, Q77ZK7, Q77ZL2, Q77ZL4, Q7TD12, Q7TPM5, Q80A33, Q89733, Q8BGD0, Q96E40, Q96FH0
Diamond homologs: Q29S20, Q8BGD0, Q9HBI5
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
7 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 2 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
773 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 3:62320458:A:AG | acceptor_gain | 1.0000 |
| 3:62320459:G:GG | acceptor_gain | 1.0000 |
| 3:62320459:GCTTT:G | acceptor_gain | 1.0000 |
| 3:62320520:GAAAT:G | donor_gain | 1.0000 |
| 3:62320525:G:GG | donor_gain | 1.0000 |
| 3:62321925:TCTA:T | acceptor_loss | 1.0000 |
| 3:62321926:CTA:C | acceptor_loss | 1.0000 |
| 3:62321927:TAGA:T | acceptor_gain | 1.0000 |
| 3:62321928:A:AG | acceptor_gain | 1.0000 |
| 3:62321929:G:GT | acceptor_gain | 1.0000 |
| 3:62321929:GA:G | acceptor_gain | 1.0000 |
| 3:62321929:GAGT:G | acceptor_gain | 1.0000 |
| 3:62321929:GAGTA:G | acceptor_gain | 1.0000 |
| 3:62322052:AGG:A | donor_loss | 1.0000 |
| 3:62322054:G:GC | donor_loss | 1.0000 |
| 3:62322054:G:GG | donor_gain | 1.0000 |
| 3:62322055:T:G | donor_loss | 1.0000 |
| 3:62331396:TGAGG:T | donor_loss | 1.0000 |
| 3:62331399:GGTG:G | donor_loss | 1.0000 |
| 3:62331400:G:A | donor_loss | 1.0000 |
| 3:62333254:GACTC:G | acceptor_gain | 1.0000 |
| 3:62319053:TCGGT:T | donor_loss | 0.9900 |
| 3:62319057:T:A | donor_loss | 0.9900 |
| 3:62319058:G:GG | donor_loss | 0.9900 |
| 3:62320021:A:T | donor_gain | 0.9900 |
| 3:62320453:A:AG | acceptor_gain | 0.9900 |
| 3:62320454:T:G | acceptor_gain | 0.9900 |
| 3:62320454:T:TA | acceptor_gain | 0.9900 |
| 3:62320459:GCTT:G | acceptor_gain | 0.9900 |
| 3:62320522:AATG:A | donor_loss | 0.9900 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000314619 (3:62332174 C>T), RS1000417449 (3:62331702 A>G), RS1000429488 (3:62325437 G>A,C,T), RS1000581506 (3:62330197 T>C,G), RS1000656427 (3:62330463 A>G), RS1000686329 (3:62317094 A>G), RS1000846387 (3:62319010 G>A,C,T), RS1000865674 (3:62325666 A>G), RS1001073481 (3:62325813 CAA>C), RS1001165031 (3:62323531 G>A,C), RS1001413484 (3:62330122 A>G), RS1001932940 (3:62323896 C>T), RS1001964044 (3:62324210 C>G), RS1002139714 (3:62317920 G>A), RS1002204283 (3:62318985 T>C)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
25 total (human), top 25 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | decreases methylation, affects cotreatment, increases expression, affects expression | 9 |
| trichostatin A | affects cotreatment, increases expression | 3 |
| potassium chromate(VI) | affects cotreatment, decreases expression | 2 |
| Benzo(a)pyrene | decreases expression, increases methylation | 2 |
| Estradiol | decreases expression, affects cotreatment | 2 |
| bisphenol A | decreases expression | 1 |
| hydroquinone | decreases expression | 1 |
| epigallocatechin gallate | decreases expression, affects cotreatment | 1 |
| gadodiamide | increases expression | 1 |
| chromium hexavalent ion | decreases expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, increases expression | 1 |
| ICG 001 | increases expression | 1 |
| dorsomorphin | affects cotreatment, increases expression | 1 |
| Sunitinib | decreases expression | 1 |
| Vorinostat | increases expression | 1 |
| Coumestrol | increases expression | 1 |
| Ketoconazole | increases expression | 1 |
| Mitoxantrone | affects response to substance | 1 |
| Mustard Gas | decreases expression | 1 |
| Progesterone | decreases expression, affects cotreatment | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Zinc | decreases expression | 1 |
| Cyclosporine | decreases expression | 1 |
| Antirheumatic Agents | decreases expression | 1 |
| Zinc Sulfate | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.